UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 19, 2013 5:00 P.M.

Form:	S-1
CIK: 0001373707 Company Name: TETRAPHASE PHARMACEUTICALS INC File Number: 333-186574